I founded a cancer biotech company. Then, my mom, dad, and I were all diagnosed with cancer.
Dr. Ryan Beal, CEO of Dyve Biosciences, shares his personal journey of founding a cancer biotech company only to be diagnosed with a rare cancer himself. His experience as both a physician and a patient has reshaped his perspective on medical innovation.
Why it matters
It provides a human-centric look at the intersection of medical research, business leadership, and personal health crises.
Dr. Ryan Beal founded a cancer-focused biotech company. Then, he got cancer himself. Courtesy of Dr. Ryan Beal Dr. Ryan Beal founded a bioscience company focused on cancer treatment in 2014. Years later, he was diagnosed with a rare cancer, and his approach to the business shifted. Being in the oncologist's office helped him understand the human impact of his innovations. This as-told-to essay is based on a conversation with Dr. Ryan Beal , CEO of Dyve Biosciences . It has been edited for length and clarity . My brother and I were about 60 miles into a 120-mile race in Colorado when chest pain made me stop. I thought I was having a cardiac emergency , but doctors diagnosed me with thymoma — a rare cancer of the thymus gland, which sits in the middle of the chest. To say it was a shock is an understatement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in